Towards control of chronic lymphocytic leukemia using chemotherapy-free combinations

被引:0
|
作者
Hallek, Michael [1 ]
机构
[1] Univ Cologne, Cologne, Germany
来源
HEMASPHERE | 2018年 / 2卷
关键词
D O I
10.1097/HS9.0000000000000125
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:51 / 52
页数:2
相关论文
共 50 条
  • [31] First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia
    Eichhorst, Barbara
    Niemann, Carsten U.
    Kater, Arnon P.
    Fuerstenau, Moritz
    von Tresckow, Julia
    Zhang, Can
    Robrecht, Sandra
    Gregor, Michael
    Juliusson, Gunnar
    Thornton, Patrick
    Staber, Philipp B.
    Tadmor, Tamar
    Lindstrom, Vesa
    da Cunha-Bang, Caspar
    Schneider, Christof
    Poulsen, Christian B.
    Illmer, Thomas
    Schoettker, Bjoern
    Noesslinger, Thomas
    Janssens, Ann
    Christiansen, Ilse
    Baumann, Michael
    Frederiksen, Henrik
    van der Klift, Marjolein
    Jaeger, Ulrich
    Leys, Maria B. L.
    Hoogendoorn, Mels
    Lotfi, Kourosh
    Hebart, Holger
    Gaska, Tobias
    Koene, Harry
    Enggaard, Lisbeth
    Goede, Jereon
    Regelink, Josien C.
    Widmer, Anouk
    Simon, Florian
    De Silva, Nisha
    Fink, Anna-Maria
    Bahlo, Jasmin
    Fischer, Kirsten
    Wendtner, Clemens-Martin
    Kreuzer, Karl A.
    Ritgen, Matthias
    Brueggemann, Monika
    Tausch, Eugen
    Levin, Mark-David
    van Oers, Marinus
    Geisler, Christian
    Stilgenbauer, Stephan
    Hallek, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (19): : 1739 - 1754
  • [32] Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale
    Masetti, Riccardo
    Muratore, Edoardo
    Leardini, Davide
    Baccelli, Francesco
    Pession, Andrea
    Prete, Arcangelo
    Locatelli, Franco
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [33] Chemotherapy-free treatment with acalabrutinib can benefit patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who were never treated before: a plain language summary of the ELEVATE-TN study
    Sharman, Jeff P.
    Hakre, Shweta
    FUTURE ONCOLOGY, 2025, 21 (07) : 737 - 748
  • [34] 'Ultralite' allogeneic HSCT: Towards a chemotherapy-free outpatient transplant regimen.
    Lim, SH
    Zhang, Y
    Chiriva-Internati, M
    Esler, WV
    Townsend, M
    Smith, P
    Burris, C
    Klug, P
    BLOOD, 2002, 100 (11) : 624A - 624A
  • [35] Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy
    Gurnari, Carmelo
    Voso, Maria Teresa
    Girardi, Katia
    Mastronuzzi, Angela
    Strocchio, Luisa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 13
  • [36] Current perspectives on the role of chemotherapy in chronic lymphocytic leukemia
    Wendtner, Clemens-Martin
    Gregor, Michael
    LEUKEMIA & LYMPHOMA, 2018, 59 (02) : 300 - 310
  • [37] COMBINATION CHEMOTHERAPY AND STAGING IN CHRONIC LYMPHOCYTIC-LEUKEMIA
    SCOUROS, MA
    MURPHY, SG
    ANDERSON, MD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 115 - 115
  • [38] TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA WITH COP CHEMOTHERAPY
    LIEPMAN, M
    VOTAW, ML
    CANCER, 1978, 41 (05) : 1664 - 1669
  • [39] What Is the Role of Chemotherapy in Patients With Chronic Lymphocytic Leukemia?
    Cheson, Bruce D.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (11): : 723 - 727
  • [40] Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?
    Øystein Bruserud
    Karl Johan Tronstad
    Emmet McCormack
    Bjørn Tore Gjertsen
    Cancer Immunology, Immunotherapy, 2006, 55 : 221 - 228